Molecular analysis reveals a high mutation frequency in the first untranslated exon of the PPOX gene and largely excludes variegate porphyria in a subset of clinically affected Afrikaner families.
A subset of probands from 11 South African families with clinical and/or biochemical features of variegate porphyria (VP), but without the known protoporphyrinogen oxidase (PPOX) gene defects identified previously in the South African population, were subjected to mutation analysis. Disease-related mutation(s) could not be identified after screening virtually the entire PPOX gene by heteroduplex single-strand conformation polymorphism analysis (HEX-SSCP), although three new sequence variants were detected in exon 1 of the gene in three normal controls. The presence of these single base changes at nucleotide positions 22 (C/G), 27 (C/A) and 127 (C/A), in addition to the known exon 1 polymorphisms I-26 and I-150, indicates that this untranslated region of the PPOX gene is particularly mutation-prone. Furthermore, microsatellite markers flanking the PPOX and alpha-1 antitrypsin (PI) gene, on chromosomes 1 and 14, respectively, were used to assess the probability of involvement of these loci in disease presentation. Common alleles transmitted from affected parent to affected child were determined where possible in the mutation-negative index cases. Allelic frequencies of these <<disease-associated>> alleles were compared to findings in the normal population, but no predominant disease-associated allele could be identified. Co-segregation of a specific haplotype with the disease phenotype could also not be demonstrated in a large Afrikaner family. It is concluded that further studies are warranted to determine the genetic factor(s) underlying the autosomal dominant pattern of inheritance in molecularly uncharacterized cases showing clinical symptoms of an acute porphyria.
Kotze
M J
MJ
Division of Human Genetics, Faculty of Medicine, University of Stellenbosch, Tygerberg.
De Villiers
J N
JN
Groenewald
J Z
JZ
Rooney
R N
RN
Loubser
O
O
Thiart
R
R
Oosthuizen
C J
CJ
van Niekerk
M M
MM
Groenewald
I M
IM
Retief
A E
AE
Warnich
L
L
D001483:Base Sequence; D020090:Chromosome Segregation; D002878:Chromosomes, Human, Pair 1; D002883:Chromosomes, Human, Pair 14; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D005091:Exons; D005260:Female; D005420:Flavoproteins; D005787:Gene Frequency; D006580:Genetic Carrier Screening; D005819:Genetic Markers; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats; D024101:Mitochondrial Proteins; D009426:Netherlands / Q000208:ethnology; D010088:Oxidoreductases / Q000235:genetics*; D044925:Oxidoreductases Acting on CH-CH Group Donors; D010375:Pedigree; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011164:Porphyrias / Q000201:enzymology / Q000235:genetics*; D050768:Protoporphyrinogen Oxidase; D013019:South Africa; D044465:White People / Q000235:genetics
D005420:Flavoproteins; D005819:Genetic Markers; D024101:Mitochondrial Proteins; D010088:Oxidoreductases; D044925:Oxidoreductases Acting on CH-CH Group Donors; C493978:PPOX protein, human; D050768:Protoporphyrinogen Oxidase